Imprimis NJOF, LLC recalls…
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac and 1 more
- Published
- 30 Jul 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Sub-Potent Drug: Subpotent assay results during stability testing.
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.
Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01
- Brand / company
- Imprimis NJOF, LLC
- Codes / lots
- Lot: 25MAR032, Exp. 07/16/2025. | Lot: 24DEC017, Exp. 07/12/2025.
- Distribution
- Nationwide in the USA
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.